• Explore /
  • Poster
  • / A pilot phase II multicenter study of nab-paclitaxel (Nab-P) and gemcitabine (G) as preoperative therapy for potentially resectable pancreatic cancer (PC).

A pilot phase II multicenter study of nab-paclitaxel (Nab-P) and gemcitabine (G) as preoperative therapy for potentially resectable pancreatic cancer (PC).

Abstract Poster

Authors

null

Shawn MacKenzie

Virginia G. Piper Cancer Center at Scottsdale Healthcare/TGen, Minneapolis, MN

Shawn MacKenzie , Herbert Zeh III, Laurence E. McCahill , Timothy D. Sielaff , Nathan Bahary , Thomas Edward Gribbin , John E. Seng , Joseph W. Leach , Jocelyn Harmon , Michael J. Demeure , Daniel D. Von Hoff , A Jim Moser , Ramesh K. Ramanathan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT01298011

Citation

J Clin Oncol 31, 2013 (suppl; abstr 4038)

DOI

10.1200/jco.2013.31.15_suppl.4038

Abstract #

4038

Poster Bd #

15H

Abstract Disclosures

Similar Posters

First Author: Thomas Jens Ettrich

First Author: Waldemar Uhl

First Author: Derek B. Grose

First Author: Thomas Jens Ettrich